# Study of A-101 Topical Solution for the Treatment of Common Warts

> **NCT03687372** · PHASE3 · COMPLETED · sponsor: **Aclaris Therapeutics, Inc.** · enrollment: 503 (actual)

## Conditions studied

- Common Wart

## Interventions

- **DRUG:** A-101
- **OTHER:** vehicle

## Key facts

- **NCT ID:** NCT03687372
- **Lead sponsor:** Aclaris Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2019-06-20
- **Final completion:** 2019-09-06
- **Target enrollment:** 503 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687372, "Study of A-101 Topical Solution for the Treatment of Common Warts". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03687372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*